Drugs & Therapy Perspectives

, Volume 10, Issue 4, pp 12–14 | Cite as

Gastric Toxicity: A Problem with Low-Dose Aspirin

Drug Reactions and Interactions
  • 6 Downloads

Keywords

Chronic Obstructive Pulmonary Disease Aspirin Misoprostol Sucralfate Gastric Damage 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Low-dose aspirin beneficial in myocardial infarction. Drug Ther Perspect 1997; 10 (4): 6–8CrossRefGoogle Scholar
  2. 2.
    Guslandi M. Gastric toxicity of antiplatelet therapy with low-dose aspirin. Drugs 1997 Jan; 53 (1): 1–5PubMedCrossRefGoogle Scholar
  3. 3.
    Bochner F, Lloyd JV. Aspirin for myocardial infarction: clinical pharmacokinetic considerations. Clin Pharmacokinet 1995; 28 (6): 433–8PubMedCrossRefGoogle Scholar
  4. 4.
    Konturek JW, Dembinski A, Stoll R, et al. Mucosal adaptation to aspirin-induced gastric damage in humans: studies on blood flow, gastric mucosal growth and neutrophil activation. Gut 1994; 35: 1197–204PubMedCrossRefGoogle Scholar
  5. 5.
    Savon JJ, Allen ML, DiMarino AJ, et al. Gastrointestinal blood loss with low dose (325mg) plain and enteric-coated aspirin administration. Am J Gastroenterol 1995; 90: 581–5PubMedGoogle Scholar
  6. 6.
    Slattery J, Warlow CP, Shorrock CJ, et al. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin — analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995; 37: 509–11PubMedCrossRefGoogle Scholar
  7. 7.
    Weil J, Colin-Jones D, Langman MJS, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827–30CrossRefGoogle Scholar
  8. 8.
    Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485–94PubMedCrossRefGoogle Scholar
  9. 9.
    Lee M, Cruer B, Feldman M. Dose effects of aspirin and gastric prostaglandins and stomach mucosal injury. Ann Intern Med 1994; 120: 184–9PubMedGoogle Scholar
  10. 10.
    Lanza F, Peace K, Gustitus L, et al. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol 1988; 83: 143–6PubMedGoogle Scholar
  11. 11.
    Goddard AF, Donnelly MT, Filipowicz B, et al. Low-dose misoprostol as prophylaxis against low-dose aspirin-induced gastroduodenal mucosal injury [abstract]. Gut 1996; 39 Suppl. 1: A33Google Scholar
  12. 12.
    British National Formulary No. 33. London: The Pharmaceutical Press, 1997 Mar: 39Google Scholar

Copyright information

© Adis International LTD 1997

Personalised recommendations